Latest News and Press Releases
Want to stay updated on the latest news?
-
BRIDGEHAMPTON, N.Y., Nov. 4, 2013 (GLOBE NEWSWIRE) -- Bridge Bancorp, Inc. (the "Company") (Nasdaq:BDGE), the holding company for The Bridgehampton National Bank (BNB), announced today that its Board...
-
REDWOOD CITY, CA--(Marketwired - Nov 4, 2013) - Qualys, Inc. (NASDAQ: QLYS), a pioneer and leading provider of cloud security and compliance solutions, today announced financial results for...
-
November 04, 2013 16:00 ET | Source: The Blue Ribbon Commission for the Advancement of Osteopathic Medical Education
WASHINGTON, DC--(Marketwired - Nov 4, 2013) - News Summary: A Blue Ribbon Commission of medical education leaders has published in a report in the November issue of Health Affairs...
-
NEW YORK, NY--(Marketwired - Nov 4, 2013) - PennantPark Floating Rate Capital Ltd. (the "Company") (NASDAQ: PFLT) declares an increase in its monthly distribution for November 2013 to...
-
NEW YORK, NY--(Marketwired - Nov 4, 2013) - Prospect Capital Corporation (NASDAQ: PSEC) ("Company" or "Prospect") today announced financial results for our first fiscal quarter ended September 30,...
-
Revenue of $143 million GAAP earnings of $0.02 per diluted share Non-GAAP earnings of $0.53 per diluted share Ended quarter with $105 million in cash FORT...
-
--Revenue and Diluted Earnings Per Share Exceed Business Outlook Range on Higher Demand --Capacity Utilization Rate Increases Alongside Seat Additions --Facility Transfers/Rationalization and...
-
BRISBANE, Calif., Nov. 4, 2013 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported...
-
Net Sales of $37.0 Million, a Sequential Increase of 7.1% GAAP EPS ($0.13); Non-GAAP EPS ($0.11) WARREN, N.J., Nov. 4, 2013 (GLOBE NEWSWIRE) -- ANADIGICS, Inc. (Nasdaq:ANAD), a leading provider...
-
MORRIS PLAINS, N.J., Nov. 4, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the...